Induction Healthcare inks three contracts with NHS trusts

Digital health platform provider Induction Healthcare updated the market on three contracts totalling £1.4m on Tuesday to enhance the functionality and development of patient portals within various NHS trusts.

The AIM-traded company said the North Central London Integrated Care System (ICS) had signed a £0.49m contract to facilitate patient interaction through the ‘Zesty’ patient portal, which allows users to view diagnostic appointment details and initiate ‘Attend Anywhere’ video consultations, spanning across three trusts.

It said the initiative would allow patients to efficiently manage their healthcare, providing them with digital tools to access services and information.

The Royal Free London NHS Foundation Trust contract, valued at £0.35m, encompassed several patient portal projects, including deploying Induction’s ‘Form Builder’ module for waitlist validation and enhanced functionality for patient-initiated follow-up (PIFU).

Recognised as crucial by the NHS for mitigating appointment backlogs, PIFU would see a substantial improvement through digital interventions, Induction claimed.

Moreover, it said it would collaborate with the Royal Free and other partners to digitalise maternity records for expecting mothers, ensuring they were available within the Zesty portal, making it the first NHS-accredited portal to offer such a facility.

Lastly, a £0.58m contract with South West London Integrated Care Board (ICB) would involve multiple patient portal projects.

It would include the Form Builder module for waitlist validations and enhance Induction’s tailored integration with Oracle Health.

The board said the integration was expected to enable data writing back to the hospital system, significantly alleviating the data processing administrative strain on trusts.

“These development and supply contracts demonstrate Induction’s growing traction in the patient platform market as we work with the NHS to give patients more choice in how their care is managed,” said chief executive officer Paul Tambeau.

“It also validates our strategy of integrating our Attend Anywhere video consultation and our Zesty patient portal platforms.”

Tambeau said the contracts also allowed the company to introduce new appointment types and deepen its technical integration with partners.

“We are also proud to be the first NHS-accredited portal provider in the UK to digitise maternity records and make it easier for expectant mothers to access their records.”

At 1525 BST, shares in Induction Healthcare Group were up 10.63% at 17.7p.

Reporting by Josh White for Sharecast.com.